Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study to Compare the Safety and Efficacy of ALZ-1101 to Latanoprost in Patients With Intraocular Pressure Inadequately Controlled by Latanoprost
Phase 2
Completed
- Conditions
- Ocular HypertensionElevated Intraocular PressurePrimary Open Angle Glaucoma
- Interventions
- First Posted Date
- 2013-07-11
- Last Posted Date
- 2014-09-30
- Lead Sponsor
- Alleanza Pharmaceuticals, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT01896180
News
No news found